Principal Securities’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.74M Buy
72,670
+16,195
+29% +$1.87M 0.13% 148
2025
Q4
$5.94M Buy
56,475
+9,229
+20% +$866K 0.09% 208
2025
Q3
$3.97M Buy
47,246
+5,794
+14% +$477K 0.07% 276
2025
Q2
$3.28M Sell
41,452
-8,668
-17% -$689K 0.06% 284
2025
Q1
$4.99M Buy
50,120
+50
+0.1% +$4.67K 0.11% 178
2024
Q4
$4.98M Sell
50,070
-2,228
-4% -$230K 0.11% 176
2024
Q3
$5.94M Buy
52,298
+617
+1% +$73.3K 0.14% 138
2024
Q2
$6.4M Buy
51,681
+7,882
+18% +$1.02M 0.18% 104
2024
Q1
$5.78M Buy
43,799
+4,041
+10% +$498K 0.18% 113
2023
Q4
$4.33M Buy
+39,758
New +$4.13M 0.16% 129

Other funds holding MRK

Principal Securities's MRK Position: Q1 2026 in Review

Principal Securities increased its Merck (MRK) stake by 29% in Q1 2026, buying an estimated $1.87M and bringing the position to 72,670 shares worth $8.74M. The position accounts for 0.13% of the portfolio, ranked #148.

Principal Securities first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Principal Securities held 72,670 shares of Merck worth $8.74M as of Q1 2026.
  • Principal Securities bought 16,195 Merck shares in Q1 2026, an estimated $1.87M.
  • Merck made up 0.13% of Principal Securities's portfolio in Q1 2026, its #148 holding.
  • Principal Securities first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Principal Securities's 13F filing for Q1 2026, filed 13 May 2026.